ABSTRACT
Preclinical and clinical development of numerous small molecules is prevented by their poor aqueous solubility, limited absorption, and oral bioavailability. Herein, we disclose a general prodrug approach that converts promising lead compounds into aminoalkoxycarbonyloxymethyl (amino AOCOM) ether-substituted analogues that display significantly improved aqueous solubility and enhanced oral bioavailability, restoring key requirements typical for drug candidate profiles. The prodrug is completely independent of biotransformations and animal-independent because it becomes an active compound via a pH-triggered intramolecular cyclization-elimination reaction. As a proof-of-concept, the utility of this novel amino AOCOM ether prodrug approach was demonstrated on an antimalarial compound series representing a variety of antimalarial 4(1H)-quinolones, which entered and failed preclinical development over the last decade. With the amino AOCOM ether prodrug moiety, the 3-aryl-4(1H)-quinolone preclinical candidate was shown to provide single-dose cures in a rodent malaria model at an oral dose of 3 mg/kg, without the use of an advanced formulation technique.
Subject(s)
Antimalarials/chemistry , Ethers/chemistry , Prodrugs/chemistry , Quinolones/chemistry , Administration, Oral , Animals , Antimalarials/pharmacokinetics , Antimalarials/pharmacology , Antimalarials/therapeutic use , Cyclization , Disease Models, Animal , Female , Half-Life , Hydrogen-Ion Concentration , Malaria/drug therapy , Malaria/parasitology , Mice , Mice, Inbred BALB C , Plasmodium falciparum/drug effects , Prodrugs/pharmacokinetics , Prodrugs/pharmacology , Prodrugs/therapeutic use , Quinolones/pharmacokinetics , Quinolones/pharmacology , Quinolones/therapeutic use , Solubility , Structure-Activity RelationshipABSTRACT
Malaria is one of the leading infectious diseases occurring mainly in tropical and subtropical areas. Although available antimalarial tools have reduced the number of fatalities, there is still an urgent need for the development of new and more efficacious treatments to cure and eradicate malaria especially due to emerging resistance to all antimalarial drugs. Research was initiated to revisit antimalarial compounds which were deemed unsuitable as a result of poor understanding of physicochemical properties and the optimization thereof. The 4(1H)-quinolones are a class of compounds with demonstrated activity against malaria parasites. Recent optimization of the long-known core led to two highly promising compounds, i.e. P4Q-391 and ELQ-300, with great selective activity against all stages of the parasite's life cycle and good physicochemical properties. In this paper, we discuss the key steps on the way to these compounds, which fuel hope to find a suitable treatment for the prevention, cure and eradication of malaria.
Subject(s)
Antimalarials/chemistry , Antimalarials/pharmacology , Plasmodium falciparum/drug effects , Quinolones/chemistry , Quinolones/pharmacology , Animals , Mice , Plasmodium falciparum/physiology , Structure-Activity RelationshipABSTRACT
Driven by the shortage of known effective possibilities for the synthesis of 4-hydroxy-3,4-dihydro-2H-1,3-thiazine-2-thiones on the one hand and the promising potential of these structures as novel drug candidates on the other hand, synthetic access to 4-hydroxy-3,4-dihydro-2H-1,3-thiazine-2-thiones was developed. The desired products could be synthesized effectively and facilely starting from ß-chlorovinyl aldehydes with the aid of a new MCR (multicomponent reaction). Furthermore, the 4-hydroxy-3,4-dihydro-2H-1,3-thiazine-2-thiones are shown to be appropriate substrates in the preparation of diverse annulated polycyclic systems.
ABSTRACT
An unexpected formation of cyclic α-alkoxy isothioureas has been achieved. As is known, the heterocyclic imines 2,5-dihydro-1,3-thiazoles are convertible to bisamides with the aid of a carboxylic acid and an isocyanide (Ugi reaction). Herein, it is shown that 2,5-dihydro-1,3-thiazole S-monoxides-the respective α-sulfinyl imines-are characterized by an altered reaction behavior. In a hitherto unknown multicomponent reaction the α-sulfinyl imines react with an isocyanide under acidic conditions in an alcoholic solution to the respective α-alkoxy isothioureas in good yields. In addition to the investigations on this unexpected synthesis the regioselectivity of the acylation of the synthesized compounds is described. A rearrangement, which is accelerated by EDC and HOBt, between both possible regioisomers was found.
Subject(s)
Cyanides/chemistry , Imines/chemistry , Thiazoles/chemistry , Thiourea/analogs & derivatives , Thiourea/chemical synthesis , Molecular Structure , Thiourea/chemistryABSTRACT
In this paper the use of a bubble column for a metal-free, selective oxidation of α-alkylthio-imines to O,S-acetals is presented. During the synthesis, which is straightforward to perform, the sulfides are oxidized to α-alkoxy- or, respectively, α-hydroxysulfide by adding activated carbon in the presence of atmospheric oxygen only. We show that the use of the bubble column, which is unusual on laboratory scale, improves the efficiency of the reaction in comparison to common laboratory techniques. As atmospheric oxygen alone is used for oxidation, this method is cost saving, environmentally friendly, and safe.
Subject(s)
Acetals/chemistry , Air , Sulfides/chemistry , Catalysis , Oxidation-Reduction , Stereoisomerism , Substrate SpecificityABSTRACT
A two-step sequence for the synthesis of various 3,4-dihydro-2H-1,3-thiazines is presented. In the first step, 2H-1,3-thiazines were prepared by a new multicomponent reaction (MCR). Starting from ß-chlorovinyl aldehydes, this MCR offers an efficient and facile access to 2,2-dialkyl- and 2-alkyl-2-aralkyl-5,6-diaryl-2H-1,3-thiazines. The potential of these products in subsequent reactions was verified by the conversion to 3,4-dihydro-2H-1,3-thiazine-containing bisamides, ß-lactams, and methoxy amides.
